Coronary artery disease and congenital cardiovascular defects often require multiple surgeries that pose a variety of serious risks to the patient. A development from Hopkins engineers could potentially minimize those surgical risks.
Sharon Gerecht was recognized for her “seminal studies on the interactions between stem cells and their microenvironments and for engineering artificial cell microenvironments capable of guiding vascular differentiation, delivery, and regeneration of tissues.”
Last summer, Rayyan Gorashi ’19 had a bucket list-worthy few months, hiking the French Alps, cheering on the Belgium national team in the FIFA World Cup, and problem-solving unanticipated setbacks as a research intern at imec.
A team led by Johns Hopkins researchers has discovered a biochemical signaling process that causes densely packed cancer cells to break away from a tumor and spread the disease elsewhere in the body.
Professors Sharon Gerecht and Hai-Quan Mao have assumed leadership of Johns Hopkins University’s Institute for NanoBioTechnology, succeeding Peter Searson and Denis Wirtz.
Supported by a $9 million grant from the National Cancer Institute, a diverse team led by Johns Hopkins researchers has begun looking for new ways to attack one of the scariest traits of cancer: its frequent refusal to stay in one place.
You may look younger than your years, but your cells won’t lie about your age, according to researchers in the…